News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
GSK and LTZ Form Strategic Collaboration to Advance Novel Myeloid Cell Engagers in Oncology
Friday, November 21, 2025GSK plc and LTZ Therapeutics an immunotherapyfocused biotechnology company in Redwood City California have entered a strategic research collaboration to develop a new class of cancer treatments known as myeloid cell engagers MCEs
European Commission Grants Conditional Marketing Authorisation for Roche's Lunsumio Subcutaneous for Relapsed or Refractory Follicular Lymphoma
Wednesday, November 19, 2025Roche secures conditional EC authorisation for Lunsumio subcutaneous a new rapidadministered treatment for relapsed or refractory follicular lymphoma in Europe
Sofinnova Partners Closes €650M Flagship Fund to Accelerate European Biotech and Medtech Innovation
Tuesday, November 18, 2025Sofinnova Partners has closed its million Sofinnova Capital XI fund targeting earlystage biotech and medtech companies across Europe and the US
Merus and Halozyme Sign Global Agreement to Develop Subcutaneous Version of Petosemtamab
Tuesday, November 18, 2025Merus NV an oncology company focused on multispecific antibodies and antibodydrug conjugates has entered into a global nonexclusive collaboration and licence agreement with Halozyme Therapeutics a specialist in subcutaneous
Sanofi Receives European Commission Approval for Sarclisa Combination Therapy in Newly Diagnosed Multiple Myeloma
Monday, November 17, 2025Sanofi gains European Commission approval for Sarclisa in combination with VRd for newly diagnosed multiple myeloma patients
Numab Therapeutics and Kaken Pharmaceutical sign licence and co-development agreement for multispecific antibody NM81 in inflammatory bowel disease (IBD)
Friday, November 14, 2025Numab Therapeutics AG a biotechnology firm developing multispecific antibodies in immunology and oncology has entered a licence and codevelopment agreement with Kaken Pharmaceutical for NM
Alvotech Accelerates European Leadership with Multiple EMA Biosimilar Approvals, Strong Q3 Performance, and Expansion of Packaging Capabilities in 2025
Friday, November 14, 2025Alvotechs Q results highlight major biosimilar approvals in Europe significant revenue growth and enhanced manufacturing capabilities through key acquisitions
Chiesi Group Signs Exclusive Licence Agreement with Aliada Therapeutics to Advance Blood–Brain Barrier Technology for Lysosomal Storage Disorders
Thursday, November 13, 2025Chiesi Group has entered into an exclusive licence agreement with Aliada Therapeutics a wholly owned subsidiary of AbbVie to develop bloodbrain barrier BBBcrossing platform technology for treating lysosomal storage disorders
European Patent Office Grants Tenax Therapeutics Landmark Patent for Levosimendan in PH-HFpEF, Paving Way for European Phase 3 Expansion
Thursday, November 13, 2025Tenax Therapeutics secures European protection for levosimendan in pulmonary hypertension with heart failure advancing pivotal trials
Evotec Receives Milestone Payment From Bristol Myers Squibb Following IND Acceptance In Strategic Protein Degradation Partnership
Wednesday, November 12, 2025Evotec has received a million milestone payment from Bristol Myers Squibb after FDA acceptance of an investigational new drug application in their Europeanbased protein degradation partnership
